MichaelEvanLidskyMD

General Surgery • Durham, NC

Hepatobiliary Surgery, Surgical Oncology (Other than Breast)

Assistant Professor of Surgery

Join to view full profile

Dr. Lidsky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lidsky's full profile

Already have an account?

Office
Duke University Medical Center
Box 3966 10 Bryan Searle Dr, 466G Seeley G. Bldg
Durham, NC 27710
Phone+1 919-684-6858

Summary

Dr. Michael Lidsky is a general surgeon in Durham, NC. He received his medical degree from Georgetown University School of Medicine and has been in practice 8 years. He specializes in hepatobiliary surgery and surgical oncology (other than breast).

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hepatopancreatobiliary Surgery, 2017 - 2018
Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2016 - 2018
Duke University HospitalResidency, Surgery, 2009 - 2016
Georgetown University School of MedicineClass of 2009

Certifications & Licensure

NC State Medical License 2009 - 2025
NY State Medical License 2015 - 2025
MO State Medical License 2018 - 2019
American Board of Surgery Surgery
American Board of Surgery Complex General Surgical Oncology

Publications & Presentations

PubMed

Perioperative and Oncologic Outcomes of Hepatic Arterial Infusion (HAI) Pump Chemotherapy for Patients with Unresectable Colorectal Liver Metastases at an Expanding HA...
Annie Liu, Melissa Lowe, Donna Niedzwiecki, Kristen E Rhodin, Jeremy Sharib
Annals of Surgical Oncology. 2025-02-01
ASO Author Reflections: Expansion of Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Colorectal Liver Metastases.
Annie Liu, Hope Uronis, Michael E Lidsky
Annals of Surgical Oncology. 2025-02-01
ASO Visual Abstract: Adjuvant Cytotoxic Chemotherapy May Not Be Associated with a Survival Advantage for Resected Intrahepatic Cholangiocarcinoma.
Jeremy Sharib, Kristen E Rhodin, Annie Liu, Sarah McIntyre, Alex Bartholomew
Annals of Surgical Oncology. 2025-01-28

Journal Articles

If the Patient Is Frail, Emergency Abdominal Surgery Is High Risk
Hadiza S Kazaure, Michael E Lidsky, JAMA Surgery
If the Patient Is Frail, Emergency Abdominal Surgery Is High Risk
Hadiza S Kazaure, Michael E Lidsky, JAMA Surgery

Press Mentions

YOUR HEALTH: The Treatment That Directly Targets Colon CancerJanuary 17th, 2020